Living Cell Technologies' DiabeCell Clinical Trial Program

February 26, 2008 - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) announced that the Company has signed a term sheet with the Barbara Davis Center for Childhood Diabetes (BDC) to establish a diabetes clinical trial program in Denver, Colorado.
BDC and LCT will collaboratively pursue regulatory approval and then conduct a U.S. clinical trial in Type 1 diabetes with DiabeCell®, LCT's encapsulated porcine insulin producing cells. The proposed U.S. trial is planned to commence in 2009 and will be planned utilizing the clinical protocols and results from LCT's trials in Russia and New Zealand... [PDF] Living Cell Technologies' Press Release -